| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 1 Sep 2025 | 1 Sep 2025 |
| Detailed Intimation is attached | ||
| Board Meeting | 11 Aug 2025 | 4 Aug 2025 |
| Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve Board Meeting intimation for consideration of Unaudited Financial Results for the quarter ended 30th June 2025 Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Monday, 11th August, 2025 which commenced at 4:00 p.m. and concluded at 4:30 p.m., for approval of Unaudited Standalone Financial Results for the quarter ended 30.06.2025. Statement showing un-audited Financial results for the quarter ended 30.06.2025 along with Limited Review Report. (As Per BSE Announcement Dated on:11.08.2025) | ||
| Board Meeting | 17 Jul 2025 | 9 Jul 2025 |
| Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2025 inter alia to consider and approve The draft notice convening the 40th Annual General Meeting of the Company; The date time and venue of the said AGM; The Directors Report for the financial year ended 31st March 2025. Fix the Book Closure dates cut-off date and E-voting dates for ensuing AGM. Appoint Scrutinizer for the e-voting process. Regularization of Additional Director. Re-appoint director retire by rotation. The appointment of a new Independent Director in place of Mrs. Chhayaben Ashwinbhai shah whose tenure has been completed as per the Companies Act 2013. Any other matter with the permission of the Chair. Outcome of Board Meeting held on 17th July, 2025. (As Per BSE Announcement Dated on: 17/07/2025) | ||
| Board Meeting | 26 May 2025 | 19 May 2025 |
| Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Audited Financial Results for quarter and year ended on 31st March 2025 Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held on Monday, the26th day of May, 2025 at 4:30 P.M. has inter- alia: (1) Approved the Audited Financial Results for quarter and year ended 31st March, 2025. We enclose here with a copy of the approved Audited Financial Results along with the Auditors Report with unmodified opinions on the aforesaid Audited Financial Results issued by M/s M.A. SHAH & Co., Chartered Accountants (FRN: 112630W), Statutory Auditors of the Company as Annexure-A. (2) Re-Appointment of M/s D.V. Shah, (Membership No.034294), Chartered Accountants( FRN No. 109551W ), as Internal Auditor of the Company for the Financial Year 2025-26. and others (As Per BSE Announcement dated on 26.05.2025) | ||
| Board Meeting | 4 Feb 2025 | 27 Jan 2025 |
| GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve Unaudited Financial Results of the company for the Quarter ended on 31st December 2024. Unaudited Financial Results for quarter ended on 31.12.2024 (As Per BSE Announcement Dated on: 04/02/2025) | ||
| Board Meeting | 28 Oct 2024 | 18 Oct 2024 |
| GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2024 Outcome of Board Meeting held on 28th October, 2024 at 06:00 pm (As per BSE Announcement dated on: 28/10/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.